Nasdaq: MENS

Jyong Biotech Ltd. (MENS)

Jyong Biotech Ltd. is a public company that reports to the U.S. Securities and Exchange Commission and trades on Nasdaq under the ticker MENS. Bright Analyst brings its financial statements, SEC filings, stock performance, news and peer comparisons together in one place, with AI analysis throughout.

Key facts

Ticker symbol
MENS
Exchange
Nasdaq
SEC CIK
1954488
Official filings
SEC EDGAR

Research MENS

  • Profile — Business description, headquarters, subsidiaries and corporate identifiers.
  • Financials — Income statement, balance sheet and cash flow from 10-K and 10-Q filings.
  • SEC Filings — Every 10-K, 10-Q and 8-K, readable inline with AI analysis.
  • Stock Analysis — Price chart, returns, technical indicators and related companies.
  • News — Latest headlines and press coverage.
  • Material Contracts — Material agreements filed as exhibits to SEC reports.
  • Benchmark — Stock performance against the S&P 500, Nasdaq-100 and Dow (through SPY, QQQ and DIA) and economic indicators.
  • Peer Comparison — Side-by-side financial ratios against industry peers.

Frequently asked questions

What is Jyong Biotech Ltd.'s stock ticker?

Jyong Biotech Ltd. trades under the ticker symbol MENS on Nasdaq. Its SEC Central Index Key (CIK) is 1954488.

Where can I read Jyong Biotech Ltd.'s SEC filings?

The MENS SEC Filings page lists the 10-K annual reports, 10-Q quarterly reports and 8-K current reports Jyong Biotech Ltd. has filed, with AI analysis. The original documents are also on SEC EDGAR.

How can I analyze MENS's financial statements?

The MENS Financials page shows Jyong Biotech Ltd.'s income statement, balance sheet and cash flow statement, annual and quarterly, taken from its XBRL filings, with an AI analysis of each statement.

How does MENS compare with its peers and the market?

The MENS Peer Comparison page lines Jyong Biotech Ltd. up against industry peers on valuation, growth and profitability ratios, and the Benchmark page compares its stock with the S&P 500, the Nasdaq-100 and the Dow.

For information only — not investment advice.